Clover Health Third Quarter 2022 - Earnings Results Clover Health Disclaimer This presentation and the accompanying oral presentations include forward-looking statements, including statements regarding future events and Clover Health Investments, Corp.'s ("Clover," "we," "our," or "us") future results of operations, financial position, market size and opportunity, business strategy and plans, and the factors affecting our performance and our objectives for future operations. These forward-looking statements ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ________________________________________ FORM 10-Q ________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 1 For the quarterly period ended September 30, 2022 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission File Number: 001-39252 _________________ ...

Clover Health Investments Corp (NASDAQ:CLOV) Q2 2022 Earnings Conference Call August 8, 2022 5:00 PM ET Company Participants Ryan Schmidt - IR Vivek Garipalli - Co-Founder, CEO & Chairman Andrew Toy - Co-Founder, President, & Director Mark Herbers - Principal Accounting Officer Conference Call Participants Richard Close - Canaccord Genuity Kevin Fischbeck - Bank of America Merrill Lynch Jason Cassorla - Citigroup Benjamin Mayo - SVB Securities Gary Taylor - Cowen and Company Operator Ladies and gentlemen, g ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ________________________________________ ________________________________________ FORM 10-Q ________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ | --- | --- | |-- ...

Clover Health Investments, Corp. (NASDAQ:CLOV) Q1 2022 Results Conference Call May 9, 2022 5:00 PM ET Company Participants Derrick Nueman - Head or Investor Relations and Corporate Strategy Vivek Garipalli - CEO Andrew Toy - President Mark Herbers - Interim CFO Conference Call Participants Richard Close - Canaccord Genuity Jason Cassorla - Citi Whit Mayo - SVB Securities Kevin Fischbeck - Bank of America Operator Ladies and gentlemen, good day and welcome to the Clover Health First Quarter 2022 Earnings Con ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ________________________________________ ________________________________________ FORM 10-Q ________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ | --- | --- | |- ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ________________________________________ FORM 10-K ________________________________________ (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR Title of each class Trading Symbol(s) Name of each exchange on which registered Class A Common Stock, par value $0.0001 per share CLOV The NASDAQ Stock Market LLC 1 o TRANSITION REPORT PURSUANT TO SECTION ...

Clover Health Investments, Corp. (NASDAQ:CLOV) Q4 2021 Earnings Conference Call February 23, 2022 5:00 PM ET | --- | --- | |-----------------------------------|-------| | | | | Company Participants | | | Derrick Nueman - VP of IR | | | Vivek Garipalli - CEO | | | Andrew Toy - President and CTO | | | Mark Herbers - CFO | | | Conference Call Participants | | | Adam Ron - Bank of America | | | Richard Close - Canaccord Genuity | | | Jonathan Yong - Credit Suisse | | | Gary Taylor - Cowen | | | Whit Mayo - SVB ...

Clover Health Investments, Corp. (NASDAQ:CLOV) Q3 2021 Earnings Conference Call November 8, 2021 5:00 PM ET Company Participants Vivek Garipalli – CEO Derrick Nueman – Vice President of Investor Relations Andrew Toy – President and CTO Mark Herbers – CFO Conference Call Participants Kevin Fischbeck – Bank of America Ralph Giacobbe – Citi Jonathan Yong – Credit Suisse Calvin Sternick – JPMorgan Gary Taylor – Cowen Operator Good day, and thank you for standing by. Welcome to the Clover Health's Third Quarter ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ________________________________________ FORM 10-Q ________________________________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Title of each class Trading Symbol(s) Name of each exchange on which registered Class A Common Stock, par value $0.0001 per share CLOV The NASDAQ Stock Market LLC 1 For the quarterly period ended September 30, 2021 OR o TRANSITION REPORT PURSUANT TO ...